This script search US Code. View Rule
Menu Item - Home
Menu Item - Agenda Main page
Menu Item - Historical Agenda
Menu Item - Historical Agenda
Menu Item - Agenda Search
Menu Item - Agenda XML Reports
Menu Item - EO Dashboard
Menu Item - Reg Review
Menu Item - EO Agency lists
Menu Item - EO Search
Menu Item - EO Historical Reports
Menu Item - Review Counts
Menu Item - OIRA Letters
Menu Item - EOM 12866 Search
Menu Item - EO XML Reports
Menu Item - ICR Dashboard page
Menu Item - ICR Main page
Menu Item - ICR Search
Menu Item - ICR XML Reports
Menu Item - FAQ
Menu Item - Additional Resources
Menu Item - Contact Us
Search: Agenda Reg Review ICR

View Rule

View EO 12866 Meetings Printer-Friendly Version     Download RIN Data in XML

HHS/FDA RIN: 0910-AG84 Publication ID: Fall 2013 
Title: Food Labeling; Gluten-Free Labeling of Foods 
Abstract: FDA is amending its regulations to define the term "gluten-free" for voluntary use in the labeling of foods. FDA is taking this action to assist persons who have celiac disease to more easily identify foods that they can eat while following a "gluten-free" diet. 
Agency: Department of Health and Human Services(HHS)  Priority: Other Significant 
RIN Status: Previously published in the Unified Agenda Agenda Stage of Rulemaking: Completed Actions 
Major: No  Unfunded Mandates: No 
CFR Citation: 21 CFR 101.91   
Legal Authority: title II of PL 108-282    21 USC 321    21 USC 331    21 USC 342    21 USC 343    21 USC 348    21 USC 371   
Legal Deadline:
Action Source Description Date
Final  Statutory    08/04/2008 
NPRM  Statutory  Publication of NPRM 01/23/2007   08/04/2006 
Action Date FR Cite
NPRM  01/23/2007  72 FR 2795   
NPRM Comment Period End  04/23/2007    
NPRM Comment Period Reopened  08/03/2011  76 FR 46671   
NPRM Comment Period Reopened End  10/03/2011  76 FR 46671   
Final Action  08/05/2013  78 FR 47154   
Regulatory Flexibility Analysis Required: Yes  Government Levels Affected: Local, State 
Small Entities Affected: Businesses  Federalism: Yes 
Included in the Regulatory Plan: No 
International Impacts: This regulatory action will be likely to have international trade and investment effects, or otherwise be of international interest.
RIN Data Printed in the FR: Yes 
Agency Contact:
Felicia Billingslea
Director, Food Labeling and Standard Staff
Department of Health and Human Services
Food and Drug Administration
Room 4D045, HFS 820, 5100 Paint Branch Parkway,
College Park, MD 20740
Phone:240 402-1803
Fax:301 436-2636

About Us   Vertical Spacer Spacer Related Resources   Vertical Spacer Spacer Disclosure   Vertical Spacer Spacer Accessibility   Vertical Spacer Spacer Privacy Policy   Vertical Spacer Spacer Contact Us